Speakers

Dr Nicolas Martelli (PharmD, PhD) is hospital pharmacist and clinical associate professor. Dr Nicolas Martelli graduated from Montpellier University obtaining a PharmD degree in 2008. He then joined the Department of Hospital Pharmacy at the European Georges Pompidou hospital (Paris, France). He continued his training obtaining a PhD in Health economics in 2015 and the same year joined the Health Economics Research Unit at the Faculty of Pharmacy - Paris-Sud University. Dr Nicolas Martelli's primary research focus is on Health Technology Assessment (HTA) and especially on medical devices. His PhD thesis was on Hospital based-HTA and innovative medical devices. He also works on Multi-criteria Decision Analysis (MCDA) by developing MCDA tools suitable for the adoption of medical devices in hospitals.

Dennis Vetter is a Ph.D. Researcher at Goethe University Frankfurt, Germany, with an M.Sc. in computer science and multiple years of industry experience as a machine learning engineer. His research is focused on trustworthy AI and its applications in healthcare, algorithmic fairness, and explanations for deep neural networks. He actively contributes to the Z-Inspection® initiative for Trustworthy AI as a technical expert and project coordinator.

Marie-Pierre Gagnon obtained her PhD in Community Health from Université Laval in 2003. She completed a postdoctoral fellowship at the Catalan Agency for Health Technology Assessment in 2004-2005, followed by another postdoctoral fellowship at the Health Telematics Unit, University of Calgary, in 2005-2006. She is currently an associate professor at the Faculty of Nursing at Université Laval. In 2012, she was awarded the Tier 2 Canada Research Chair in Technologies and Practices in Health. Her research program focuses on the use of scientific evidence in the implementation of innovative technologies, particularly Information and Communication Technologies (ICT) in healthcare. Her other research interests include health technology assessment (HTA) and its impact on decision making, the study of individual, professional and organizational determinants of ICT integration in the healthcare system, patient participation in healthcare decisions, and best practices in knowledge translation and application.

Vice President of Product in iGenius, in charge of the strategy and execution of effective Product delivery, managing and growing an exceptional organization. Previous experiences as Head of Data Science & AI at Sky, Lead of AI at Accenture, R&D Manager at IIGM and CSO of aGrisù. Cross Functional Leadership managing tech teams including Integration, Self-Service, Augmented Analytics, Conversational AI, Data Engineering, Apps (Web & Mobile), Technology, DevOps, QA & Support, Testing, Product Design (UX & UI) and Product Management. 15 years’ experience in relevant industries building a state of art of data-driven solutions through data science and AI products. Ph.D. in Data Science & Artificial Intelligence, experience in research and development environments in cross- country and cross-industry context. Focus: Decision Intelligence, Total experience, Augmented Consumer, Generative AI, Composable Applications, Augmented Analytics, Conversational AI, Hyper-automation. Mission: “Looking for a brain that can be integrated in a multitude of high impactful data-driven business applications to better support the customer experience”. Adjunct Professor at University of Pavia and Turin. Author of more than 100 research publications and 2 books and Reviewer and Editor for high impacted Journals

My scientific career has been always tied to the biomedical field. After I graduated, I joined the cROS group, led by Prof. Ana Coto-Montes at Oviedo University. During my PhD studies, I studied wide-ranging effects of autophagy in several models and published 17 papers in peer-reviewed journals. I also earned a fellowship for 4 years from the Instituto de Salud Carlos III (PFIS FI10-00065). The models and topics I explored included ageing, tenderization of commercial meat and the Harderian gland. I used the latter to study the relationship between autophagy and lipid metabolism. I sought to expand my knowledge in lipophagy with a short stay in the laboratory of Dr Rajat Singh at Albert Einstein College of Medicine (NY, USA). After my PhD, I rejoined Singh lab as a postdoctoral fellow to study lipophagy regulation. I learnt critical procedures in mice, and I contributed to 2 Cell Metabol papers. In January 2016, I moved along with Singh lab from NY to Newcastle University. My management skills were crucial to set up this new lab branch. I also mentored a master student and a technician volunteer. I got exciting collaborations: I studied the role of lipophagy in a model of glioblastoma with Dr. Oliver (IPBLN-CSIC, Spain). This collaboration provided very interesting results which are in the second revision in Cell Death & Disease. I studied how autophagy mediates cell death in chondrocytes together with Prof. Marlow (Icahn School of Medicine at Mount Sinai, NY, USA). This collaboration resulted in a manuscript published in a Q1 journal (PLOS Gen). After Dr. Singh went back to NY, I contacted Prof. Derek Mann and became a member of the Fibrosis lab in January 2017. There I led different projects. One about the connection between epigenetics and fibrosis through MeCP2, published in Gastroenterology where I am the first author. My expertise in Seahorse helped to understand defective macrophage polarization in cRelKO mice (second author in Nat Metab) and was crucial to set up a new ex vivo system for human liver slices (Hepatology). I had also the opportunity to develop my own project: “mTOR role in lipid droplet biogenesis” funded by Newcastle University (C0120R3166), which manuscript is published at Hepatology. I broaden my network of collaborations and I was co-PI in a Wellcome Trust Small Grant with the project Implications of autophagy in cardiac myopathies (BH182173). In January 2019, I joined the Neuroenergetics and Metabolism lab, led by Prof. Bolaños, with a Sara Borrell postdoctoral contract (CD18-00203). I am contributing to several projects funded by Ramon Areces, BBVA, and MICINN, with a co-first authorship paper recently published in Nature Communications. I am also in charge of the project Dissecting neuron-to-liver crosstalk to modulate lipid metabolism in Batten disease. The preliminary results of this project have been published as a proceeding in the 3rd ranked journal in the field, Alzheimer’s & Dementia (IF 21.566), amongst abstracts in other international conferences. In sum, as a result of this Sara Borrell postdoctoral fellow, I have published 6 papers and I got funds to help start with a new stage of my scientific career. Since January 2022, I became a young PI after obtaining grants from the Francisco Cobos Foundation (to cover my current salary) and Eugenio Rodriguez Pascual Foundation to boost my career as an independent researcher to develop my own research line on the implication of liver lipophagy in lysosomal storage disorders. In this period, I published a paper as a senior author in a D1 journal (Antioxidants).